Colchicine Against SARS-CoV-2 Infection: What is the Evidence?

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of concern worldwide and a huge challenge for rheumatologists. Indeed, several antirheumatic drugs are currently used at different stages of COVID-19, such as several cytokine i...

Descripción completa

Detalles Bibliográficos
Autores principales: Drosos, Alexandros A., Pelechas, Eleftherios, Drossou, Vassiliki, Voulgari, Paraskevi V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808271/
https://www.ncbi.nlm.nih.gov/pubmed/35107804
http://dx.doi.org/10.1007/s40744-022-00425-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808271/
https://www.ncbi.nlm.nih.gov/pubmed/35107804
http://dx.doi.org/10.1007/s40744-022-00425-0

Ejemplares similares